Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

New Opioids May Need Comparative Effectiveness Data For Approval

Jun 21 2019

• By Brenda Sandburg

Closeup of risk and benefit wooden blocks on seesaw against gray background - Image

Related Content

Dsuvia's Thumbs Up From US FDA Advisory Panel Is First Positive Vote For An Opioid In 2018

Oct 15 2018

Will US FDA Remove Higher Strength Opioids From The Market?

Jun 17 2019

US FDA's Benefit-Risk Assessment Could Include More Emphasis on Patient Involvement

May 29 2019

Opioid Blister Pack Mandate Could Be Phased-In Based On Prescription Volume

May 30 2019

Dsuvia Approval May Be Followed By New Opioid Review Paradigm At FDA

Nov 02 2018

Related Companies

Talphera, Inc.

Additional Topics

Guidance Documents FDA Clinical Trials Drug Approval Standards Regulation BioPharmaceutical

More from US FDA

More from Agency Leadership

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window